Physician profile
Richard C Seestedt
NPI 1104895630
$1,820.30
in general payments reported to CMS, 2019-2025
24 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $740 · 2020: $209 · 2022: $144 · 2024: $582 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $750.08 | 2019-2024 | Austedo Xr, Ajovy |
| Abbvie INC. | $220.35 | 2022-2025 | |
| Lilly USA, LLC | $160.04 | 2024 | Kisunla, Amyvid |
| Astrazeneca Pharmaceuticals Lp | $94.68 | 2024 | Andexxa |
| Allergan, INC. | $63.48 | 2019-2020 | |
| Biogen, INC. | $59.85 | 2019 | |
| Supernus Pharmaceuticals, INC. | $48.64 | 2019 | |
| Pfizer INC. | $44.73 | 2019-2024 | |
| Genzyme Corporation | $43.86 | 2019 | |
| Novartis Pharmaceuticals Corporation | $42.89 | 2019 | |
| Amgen INC. | $34.56 | 2019 | |
| Upsher-Smith Laboratories LLC | $33.58 | 2019-2020 | |
| Emd Serono, INC. | $25.38 | 2019 | |
| Ge Healthcare | $23.41 | 2019 | |
| Sunovion Pharmaceuticals INC. | $22.40 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $20.99 | 2019 | |
| Alexion Pharmaceuticals, INC. | $19.49 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $18.95 | 2019 | |
| Adamas Pharmaceuticals, INC. | $17.52 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $16.50 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $15.98 | 2024 | Rexulti |
| Vertical Pharmaceuticals, LLC | $14.91 | 2019 | |
| Avanir Pharmaceuticals, INC. | $14.89 | 2019 | |
| Acorda Therapeutics, INC | $13.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Seestedt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.